Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.93M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ATRCAtriCure, Inc.	39,859	$33.66	$1.34M	70%	2026-05-18
FLGTFulgent Genetics, Inc.	28,099	$20.85	$585.9K	30%	2026-05-14

ATRC

AtriCure, Inc.

$1.34M

39,859 sh

FLGT

Fulgent Genetics, Inc.

$585.9K

28,099 sh

All filings on record

Every Form 4 transaction we track for this filer

all 3buys 0sells 1

Stock	Transaction	Date	~6mo later
ATRCAtriCure, Inc.	Grant — · 6,144 sh	2026-05-18	—
FLGTFulgent Genetics, Inc.	Grant — · 11,117 sh	2026-05-14	—
ATRCAtriCure, Inc.	Sell $90.3K · 2,452 sh	2025-08-06	—

ATRCGrant

2026-05-18 · AtriCure, Inc.

6,144

—

FLGTGrant

2026-05-14 · Fulgent Genetics, Inc.

11,117

—

ATRCSell

2025-08-06 · AtriCure, Inc.

$90.3K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.